Jack Feehan

Mr. Jack Feehan

Institute for Health and Sport, Victoria University, Melbourne, VIC 3011, Australia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2020 in Current Osteoporosis Reports
Verified
Journal Article
Closed access
PDF file
BKBen Kirk
Ben Kirk
Jack FeehanJack Feehan
Jack Feehan
Giovanni LombardiGiovanni Lombardi
Giovanni Lombardi
Gustavo DuqueGustavo Duque
Gustavo Duque

1 January 2021 in Maturitas
Verified
Journal Article
Closed access
HSHira Shakoor
Hira Shakoor
Jack FeehanJack Feehan
Jack Feehan
ADAyesha S. Al Dhaheri
Ayesha S. Al Dhaheri
Habiba I. AliHabiba I. Ali
Habiba I. Ali
CPCarine Platat
Carine Platat
Lily StojanovskaLily Stojanovska
Lily Stojanovska

25 February 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
HSHira Shakoor
Hira Shakoor
Jack FeehanJack Feehan
Jack Feehan
Vasso ApostolopoulosVasso Apostolopoulos
Vasso Apostolopoulos
CPcarine platat
carine platat
Ayesha Al DhaheriAyesha Al Dhaheri
Ayesha Al Dhaheri
Lily StojanovskaLily Stojanovska
Lily Stojanovska
Functional and nutraceutical foods provide an alternative way to improve immune function to aid in the management of various diseases. Traditionally, many medicinal products have been derived from natural compounds with healing properties. With the development of research into nutraceuticals, it is becoming apparent that many of the beneficial properties of these compounds are at least partly due to the presence of polyphenols. There is evidence that dietary polyphenols can influence dendritic cells, have an immunomodulatory effect on macrophages, increase proliferation of B cells, T cells and suppress Type 1 T helper (Th1), Th2, Th17 and Th9 cells. Polyphenols reduce inflammation by suppressing the pro-inflammatory cytokines in inflammatory bowel disease by inducing Treg cells in the intestine, inhibition of tumor necrosis factor-alpha (TNF-α) and induction of apoptosis, decreasing DNA damage. Polyphenols have a potential role in prevention/treatment of auto-immune diseases like type 1 diabetes, rheumatoid arthritis and multiple sclerosis by regulating signaling pathways, suppressing inflammation and limiting demyelination. In addition, polyphenols cause immunomodulatory effects against allergic reaction and autoimmune disease by inhibition of autoimmune T cell proliferation and downregulation of pro-inflammatory cytokines (interleukin-6 (IL-6), IL-1, interferon-γ (IFN-γ)). Herein, we summarize the immunomodulatory effects of polyphenols and the underlying mechanisms involved in the stimulation of immune responses.

10 January 2025 in The Journal Of Prevention of Alzheimer's Disease
Verified
Journal Article
Open access
ZVZachary Valiukas
Zachary Valiukas
KTKathy Tangalakis
Kathy Tangalakis
Vasso ApostolopoulosVasso Apostolopoulos
Vasso Apostolopoulos
Jack FeehanJack Feehan
Jack Feehan
Alzheimer's Disease (AD) is a chronic neurodegenerative disorder characterized by the accumulation of toxic amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) of tau protein in the brain. Microglia, key immune cells of the central nervous system, play an important role in AD development and progression, primarily through their responses to Aβ and NFTs. Initially, microglia can clear Aβ, but in AD, chronic activation overwhelms protective mechanisms, leading to sustained neuroinflammation that enhances plaque toxicity, setting off a damaging cycle that affects neurons, astrocytes, cerebral vasculature, and other microglia. Current AD treatments have been largely ineffective, though emerging immunotherapies focusing on plaque removal show promise, but often overlook the role of neuroinflammation. Activated microglia display a complex range of phenotypes that can be broadly broken into pro- or anti-inflammatory states, although this dichotomy does not describe the significant overlap between states. Aβ can strongly induce inflammatory activity, triggering the production of reactive oxygen species, inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6), synapse engulfment, blood-brain barrier compromise, and impaired Aβ clearance. These processes contribute to neural tissue loss, manifesting as cognitive decline such as impaired executive function and memory. Conversely, anti-inflammatory activation exerts neuroprotective effects by suppressing inflammatory pathways and releasing neurotrophic factors that aid neuron repair and protection. Induction of anti-inflammatory states may offer a dual therapeutic approach to address both neuroinflammation and plaque accumulation in AD. This approach suggests potential strategies to modulate microglial phenotypes, aiming to restore neuroprotective functions and mitigate disease progression by simultaneously targeting inflammation and plaque pathology.

1 February 2019 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
ASAhmed Al Saedi
Ahmed Al Saedi
Jack FeehanJack Feehan
Jack Feehan
SPSteven Phu
Steven Phu
Gustavo DuqueGustavo Duque
Gustavo Duque
The term “frailty” is used to describe a subset of older adults who appear weaker and more vulnerable than their age-matched counterparts, despite having similar comorbidities, demography, sex, and age. The diagnosis of frailty is usually clinical and based on specific criteria, which are sometimes inconsistent. Therefore, there is an increasing need to identify and validate robust biomarkers for this condition. In this review, we summarize current evidence on the validity and practicality of the most commonly used biomarkers for frailty, while also comparing them with new upcoming strategies to identify this condition.

1 February 2021 in Maturitas
Verified
Journal Article
Closed access
HSHira Shakoor
Hira Shakoor
Jack FeehanJack Feehan
Jack Feehan
KMKathleen Mikkelsen
Kathleen Mikkelsen
ADAyesha S. Al Dhaheri
Ayesha S. Al Dhaheri
Habiba I. AliHabiba I. Ali
Habiba I. Ali
Vasso ApostolopoulosVasso Apostolopoulos
Vasso Apostolopoulos